US EditionContaminant Litigation Risks May Affect DuPont Valuation, Analyst Downgrades Stock - DuPont de Nemours (NYSE:DD)
Summary by Benzinga
1 Articles
1 Articles
All
Left
Center
1
Right
Contaminant Litigation Risks May Affect DuPont Valuation, Analyst Downgrades Stock - DuPont de Nemours (NYSE:DD)
Bank of America Securities analyst Steve Byrne downgrades DuPont de Nemours Inc (NYSE: DD) stock from Buy to Underperform, raising the price target from $78 to $80. Citing concerns over DuPont's modest earnings recovery in 2024, undervalued PFAS liabilities, and the $1.2 billion AFFF MDL settlement, Byrne highlights potential risks from PFAS news flow and personal injury litigation, despite increased EPS estimates due to improvements in U.S. hou…
·New York, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
